The Ensign Group, Inc. (NASDAQ:ENSG) Director Daren Shaw sold 1,000 shares of The Ensign Group stock in a transaction on Friday, July 24th. The shares were sold at an average price of $45.56, for a total value of $45,560.00. Following the sale, the director now directly owns 46,125 shares of the company’s stock, valued at $2,101,455. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Daren Shaw also recently made the following trade(s):
- On Monday, July 27th, Daren Shaw sold 2,375 shares of The Ensign Group stock. The stock was sold at an average price of $45.29, for a total value of $107,563.75.
- On Wednesday, June 3rd, Daren Shaw sold 500 shares of The Ensign Group stock. The shares were sold at an average price of $45.00, for a total value of $22,500.00.
NASDAQ:ENSG opened at $46.55 on Friday. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of 20.18, a PEG ratio of 1.30 and a beta of 0.83. The Ensign Group, Inc. has a 52 week low of $24.06 and a 52 week high of $63.00. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 1.94. The firm has a 50 day moving average of $42.76 and a 200 day moving average of $41.99.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.43%. The ex-dividend date of this dividend is Monday, June 29th. The Ensign Group’s dividend payout ratio (DPR) is presently 9.57%.
A number of research firms recently weighed in on ENSG. Royal Bank of Canada reaffirmed a “buy” rating and issued a $48.00 price objective on shares of The Ensign Group in a research note on Monday, April 20th. BidaskClub cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, June 20th. Stephens reissued a “hold” rating and set a $40.00 price objective on shares of The Ensign Group in a report on Tuesday, May 12th. Zacks Investment Research upgraded The Ensign Group from a “hold” rating to a “buy” rating and set a $39.00 target price for the company in a report on Monday, May 11th. Finally, SunTrust Banks lifted their price target on The Ensign Group from $46.00 to $50.00 and gave the company a “hold” rating in a report on Thursday, June 11th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The Ensign Group has a consensus rating of “Buy” and an average price target of $50.29.
Several hedge funds have recently modified their holdings of ENSG. Wasatch Advisors Inc. increased its holdings in shares of The Ensign Group by 17.3% during the first quarter. Wasatch Advisors Inc. now owns 5,585,805 shares of the company’s stock valued at $210,082,000 after acquiring an additional 825,329 shares in the last quarter. State Street Corp grew its position in The Ensign Group by 6.8% during the 1st quarter. State Street Corp now owns 1,652,519 shares of the company’s stock worth $62,233,000 after purchasing an additional 105,222 shares during the last quarter. Copeland Capital Management LLC grew its position in The Ensign Group by 9.2% during the 2nd quarter. Copeland Capital Management LLC now owns 928,187 shares of the company’s stock worth $38,844,000 after purchasing an additional 78,565 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in The Ensign Group by 204,560.4% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 920,972 shares of the company’s stock valued at $34,638,000 after purchasing an additional 920,522 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of The Ensign Group in the fourth quarter worth $34,424,000. Institutional investors and hedge funds own 83.33% of the company’s stock.
About The Ensign Group
The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, such as daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.
Featured Story: 52- Week Highs
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.